Total: 1331, Nodes: 439, Word count: 3586, All words count: 5382
View: Overview. Sorted by number of publications (Pubs). Page 3 of 7: [  1  2  3  4  5  6  7 ]

#	Word	Pubs	Percent	TLCS	TGCS
401	METABOLISM	2	0.5	18	80
402	METHODS	2	0.5	0	54
403	MICROVILLAR	2	0.5	4	261
404	MIDDLE	2	0.5	5	202
405	MITOGENIC	2	0.5	13	239
406	MNK	2	0.5	6	488
407	MODEL	2	0.5	11	292
408	MODIFICATION	2	0.5	1	64
409	MOLECULAR	2	0.5	7	176
410	MOLECULAR-CLONING	2	0.5	0	64
411	MONOCLONAL-ANTIBODIES	2	0.5	12	136
412	MOSAIC	2	0.5	1	15
413	NCK	2	0.5	11	371
414	NITROGEN-MUSTARD	2	0.5	3	225
415	NON-DEFECTIVE	2	0.5	1	22
416	NORMAL	2	0.5	2	56
417	NUCLEOPROTEIN	2	0.5	2	65
418	ONCOGENE	2	0.5	5	990
419	ONCOGENIC	2	0.5	1	675
420	ONCOPROTEIN	2	0.5	3	606
421	OVERVIEW	2	0.5	2	76
422	P130GAG-FPS	2	0.5	5	16
423	PDGF	2	0.5	11	902
424	PEPTIDES	2	0.5	1	460
425	PHOSPHOAMINO	2	0.5	36	1402
426	PHOSPHOLIPASE	2	0.5	0	127
427	PHOSPHOPEPTIDE	2	0.5	36	1402
428	PHOSPHORYLATE	2	0.5	7	250
429	PHYSIOLOGICAL	2	0.5	4	553
430	PLATES	2	0.5	36	1402
#	Word	Pubs	Percent	TLCS	TGCS
431	POMBE	2	0.5	2	39
432	POSSIBLE	2	0.5	9	90
433	POSTGENOMIC	2	0.5	0	0
434	PP60SRC	2	0.5	14	218
435	PRC	2	0.5	6	120
436	PRC-II	2	0.5	3	37
437	PRESENT	2	0.5	31	221
438	PROCESSES	2	0.5	2	39
439	PROPERTIES	2	0.5	0	124
440	PROTEIN-TYROSINE-PHOSPHATASE	2	0.5	10	59
441	PROTOONCOGENES	2	0.5	0	1
442	QUIESCENT	2	0.5	10	177
443	RAPID	2	0.5	35	1525
444	RECEPTOR-B	2	0.5	1	23
445	RECONSTRUCTION	2	0.5	3	22
446	REDUCES	2	0.5	15	700
447	REGULATOR	2	0.5	10	815
448	REGULATORY	2	0.5	1	189
449	RELATIONSHIP	2	0.5	8	71
450	RESCUE	2	0.5	0	13
451	RESISTANCE	2	0.5	1	28
452	RESPONSE	2	0.5	6	55
453	RESTRICTED	2	0.5	1	91
454	RESTRICTION	2	0.5	8	124
455	RIBOSOMAL-PROTEIN	2	0.5	2	50
456	RING	2	0.5	1	116
457	SAP-1A	2	0.5	4	218
458	SARCOMA	2	0.5	2	13
459	SCHIZOSACCHAROMYCES	2	0.5	2	39
460	SCLEROSIS	2	0.5	1	5
#	Word	Pubs	Percent	TLCS	TGCS
461	SEGREGATION	2	0.5	1	26
462	SEQUENCE-SPECIFIC	2	0.5	8	1292
463	SEQUENCING	2	0.5	4	214
464	SERINES	2	0.5	8	40
465	SIMIAN	2	0.5	6	64
466	SOMATIC	2	0.5	1	35
467	SPECIFIED	2	0.5	1	15
468	SPINDLE	2	0.5	0	97
469	STATE	2	0.5	2	260
470	STELLATE	2	0.5	0	1
471	STIMULATED	2	0.5	12	144
472	STIMULATION	2	0.5	1	36
473	STRESS	2	0.5	3	157
474	SUBSTRATE-P	2	0.5	14	236
475	SURFACE	2	0.5	13	128
476	SURVIVIN	2	0.5	2	84
477	SV40-SPECIFIC	2	0.5	9	76
478	TAIL	2	0.5	4	300
479	TEMPERATURE	2	0.5	2	21
480	THIN-LAYER	2	0.5	36	1402
481	TOBACCO	2	0.5	3	47
482	TRANSFORMED-CELLS	2	0.5	14	224
483	TRANSLOCATION	2	0.5	1	5
484	TRANSMISSION	2	0.5	6	500
485	TREATMENT	2	0.5	6	210
486	TUBEROUS	2	0.5	1	5
487	TYPE	2	0.5	2	285
488	TYPE-2-SV	2	0.5	9	76
489	USE	2	0.5	3	462
490	V-FPS	2	0.5	0	155
#	Word	Pubs	Percent	TLCS	TGCS
491	V-MOS	2	0.5	2	13
492	VARIANTS	2	0.5	2	69
493	VERTEBRATE	2	0.5	7	176
494	VITRO	2	0.5	3	168
495	WEDGE	2	0.5	6	131
496	WEE	2	0.5	1	35
497	30S	1	0.2	0	0
498	A-KINASE-ANCHORING	1	0.2	0	0
499	A-TYPE	1	0.2	5	59
500	A431-CELL	1	0.2	2	49
501	A431-CELLS	1	0.2	7	30
502	ABILITY	1	0.2	6	54
503	ABOLISHES	1	0.2	0	49
504	ABROGATES	1	0.2	7	118
505	ACCOMPANY	1	0.2	3	89
506	ACCUMULATION	1	0.2	1	127
507	ACTIN	1	0.2	4	40
508	ACTINS	1	0.2	0	28
509	ACTIONS	1	0.2	0	3
510	ACTIVATED	1	0.2	2	57
511	ACTIVATOR	1	0.2	0	53
512	ACTIVITIES	1	0.2	5	116
513	AD2-SV	1	0.2	0	0
514	ADAPTER	1	0.2	8	103
515	ADAPTOR	1	0.2	7	284
516	ADDITIONAL	1	0.2	4	58
517	ADENOVIRUS-SV	1	0.2	1	15
518	ADHESION-INDEPENDENT	1	0.2	0	20
519	AFFAIR	1	0.2	0	1
520	AFFECTS	1	0.2	1	123
#	Word	Pubs	Percent	TLCS	TGCS
521	AGE	1	0.2	10	1697
522	AGE-DEPENDENT	1	0.2	0	31
523	AGENTS	1	0.2	10	149
524	ALLIANCE	1	0.2	2	41
525	ALPHA-ACTIN	1	0.2	6	145
526	ALPHA-V	1	0.2	0	173
527	ALTERATIONS	1	0.2	3	89
528	ALTERNATIVELY	1	0.2	0	9
529	AMINO-ACIDS	1	0.2	18	288
530	AMINO-TERMINAL	1	0.2	3	8
531	AMPHIBIAN	1	0.2	0	0
532	ANAPLASTIC	1	0.2	0	6
533	ANCHORAGE	1	0.2	4	300
534	ANNEXIN	1	0.2	0	9
535	ANTERIOR-PITUITARY-CELLS	1	0.2	0	49
536	ANTI-APOPTOTIC	1	0.2	2	84
537	ANTI-IGM-INDUCED	1	0.2	2	50
538	ANTI-P	1	0.2	8	49
539	ANTI-PHOSPHATASES	1	0.2	3	33
540	ANTI-PHOSPHOLIPASE	1	0.2	4	87
541	ANTI-SERUM	1	0.2	0	9
542	ANTIBODY	1	0.2	0	6
543	ANTIGENIZED	1	0.2	0	6
544	ANTIGENS	1	0.2	5	44
545	ANTIOXIDANTS	1	0.2	0	0
546	ANTISERA	1	0.2	1	17
547	APC	1	0.2	6	88
548	APPARENTLY	1	0.2	1	103
549	APPLICATION	1	0.2	3	8
550	ARK	1	0.2	1	26
#	Word	Pubs	Percent	TLCS	TGCS
551	ARRANGEMENT	1	0.2	2	84
552	ARRESTED	1	0.2	6	165
553	ASSAY	1	0.2	0	12
554	ASSIGNMENT	1	0.2	1	32
555	ASSOCIATES	1	0.2	0	0
556	ASYMMETRY	1	0.2	0	31
557	ATLV	1	0.2	0	0
558	ATM	1	0.2	0	3
559	ATRIAL	1	0.2	3	31
560	ATT	1	0.2	0	9
561	AURORA-RELATED	1	0.2	1	26
562	AUTOREGULATION	1	0.2	0	3
563	AVIAN	1	0.2	1	65
564	B-CELL	1	0.2	2	50
565	B-TYPE	1	0.2	4	38
566	BAD	1	0.2	3	150
567	BAND-4.	1	0.2	1	206
568	BARD	1	0.2	0	33
569	BASAL	1	0.2	3	32
570	BEDFELLOWS	1	0.2	0	1
571	BEHAVES	1	0.2	19	658
572	BETA-ACTIN	1	0.2	6	145
573	BETA-CATENIN	1	0.2	0	5
574	BETA-D-ARABINOFURANOSYL	1	0.2	1	24
575	BETA-SUBUNIT	1	0.2	0	173
576	BETA-TRCP	1	0.2	1	35
577	BETA-TREATED	1	0.2	3	129
578	BHK	1	0.2	3	32
579	BHK-21-CELLS	1	0.2	2	260
580	BHKZ	1	0.2	1	40
#	Word	Pubs	Percent	TLCS	TGCS
581	BIND	1	0.2	6	54
582	BINDING-AFFINITY	1	0.2	2	100
583	BIOCHEMICAL-ANALYSIS	1	0.2	1	18
584	BIOSYNTHESIS	1	0.2	0	0
585	BIR1P	1	0.2	0	0
586	BLOCK	1	0.2	0	15
587	BLOOD	1	0.2	2	49
588	BODY	1	0.2	0	38
589	BOMBESIN	1	0.2	2	123
590	BOMBESIN-RELATED	1	0.2	2	123
591	BOX	1	0.2	0	43
592	BRAIN-DERIVED	1	0.2	4	538
593	BRAKING	1	0.2	3	395
594	BRASSINOSTEROID-INSENSITIVE	1	0.2	1	93
595	BRI	1	0.2	0	3
596	BUNDLING	1	0.2	0	59
597	BYSTANDERS	1	0.2	4	32
598	C-CBL	1	0.2	9	498
599	C-SRC-AND	1	0.2	3	194
600	C-TERMINUS	1	0.2	1	16

Page 3 of 7: [  1  2  3  4  5  6  7 ]